Services

Development and Strategy

Orchid helps companies articulate and advance development plans that are technically sound, capital-efficient, and aligned with commercial realities. Services include:

Translational and early clinical development strategy
IND-enabling and preclinical roadmap design
Gap analyses and milestone definition
Portfolio prioritization and feasibility assessments

The firm’s approach emphasizes clarity, defensibility, and investor-aligned decision-making.

Fundraising and Investor Readiness

Orchid supports companies preparing to raise capital or engage investors, ensuring that the scientific, clinical, and business narratives are coherent and compelling. Support includes:

Investor materials (pitch decks, data packages, one-pagers)
Market positioning and story development
Investor mapping across biotech VC, strategics, and family offices
Diligence preparation and engagement

Orchid focuses on building a foundation that accelerates (not complicates) the fundraising process.

Business Development and Partnering

Orchid helps teams evaluate and pursue strategic partnerships, including in- and out-licensing opportunities. Services include:

Landscape assessment and partner prioritization
Deal narratives and partnering materials
Scientific and commercial positioning
Coordination with legal, regulatory, and technical advisors

Aim to make partnering conversations straightforward, credible, and strategically aligned.

Interim and Fractional Leadership

For companies navigating key moments (financings, partnerships, or clinical inflection points) Orchid provides flexible leadership support, including:

Interim executive, strategy, or business development leadership
Fractional business development or fundraising support
Board-level advisory
Integration with existing investor or operational teams

Companies gain access to senior expertise without committing to long-term full-time hires.